ATE534667T1 - Anti-abeta antikörper - Google Patents

Anti-abeta antikörper

Info

Publication number
ATE534667T1
ATE534667T1 AT05723280T AT05723280T ATE534667T1 AT E534667 T1 ATE534667 T1 AT E534667T1 AT 05723280 T AT05723280 T AT 05723280T AT 05723280 T AT05723280 T AT 05723280T AT E534667 T1 ATE534667 T1 AT E534667T1
Authority
AT
Austria
Prior art keywords
abeta
abeta antibodies
free
low levels
abeta peptide
Prior art date
Application number
AT05723280T
Other languages
German (de)
English (en)
Inventor
Ronald Demattos
Uma Kuchibhotla
Hsiu-Chiung Yang
Don Mcclure
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE534667T1 publication Critical patent/ATE534667T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT05723280T 2004-02-23 2005-02-17 Anti-abeta antikörper ATE534667T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54676404P 2004-02-23 2004-02-23
PCT/US2005/005198 WO2005082939A2 (en) 2004-02-23 2005-02-17 Anti-abeta antibody

Publications (1)

Publication Number Publication Date
ATE534667T1 true ATE534667T1 (de) 2011-12-15

Family

ID=34910810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05723280T ATE534667T1 (de) 2004-02-23 2005-02-17 Anti-abeta antikörper

Country Status (20)

Country Link
US (1) US20070190046A1 (cg-RX-API-DMAC7.html)
EP (1) EP1720909B1 (cg-RX-API-DMAC7.html)
JP (1) JP4851348B2 (cg-RX-API-DMAC7.html)
KR (2) KR100889430B1 (cg-RX-API-DMAC7.html)
CN (1) CN1922209B (cg-RX-API-DMAC7.html)
AT (1) ATE534667T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005217596B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0507856A (cg-RX-API-DMAC7.html)
CA (1) CA2556436C (cg-RX-API-DMAC7.html)
CY (1) CY1112162T1 (cg-RX-API-DMAC7.html)
DK (1) DK1720909T3 (cg-RX-API-DMAC7.html)
EA (1) EA009872B1 (cg-RX-API-DMAC7.html)
ES (1) ES2375627T3 (cg-RX-API-DMAC7.html)
IL (1) IL177611A (cg-RX-API-DMAC7.html)
NO (1) NO20064239L (cg-RX-API-DMAC7.html)
PL (1) PL1720909T3 (cg-RX-API-DMAC7.html)
PT (1) PT1720909E (cg-RX-API-DMAC7.html)
SI (1) SI1720909T1 (cg-RX-API-DMAC7.html)
UA (1) UA93181C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005082939A2 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
PL1976877T5 (pl) 2005-11-30 2017-09-29 Abbvie Inc Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
PT1954718E (pt) 2005-11-30 2014-12-16 Abbvie Inc Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos
MX358175B (es) 2005-12-12 2018-08-08 Ac Immune Sa Anticuerpos monoclonales especificos 1-42 beta con propiedades terapeuticas.
US7892544B2 (en) 2006-07-14 2011-02-22 Ac Immune Sa Humanized anti-beta-amyloid antibody
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
HRP20140049T1 (hr) 2007-01-05 2014-02-28 University Of Zürich Anti beta-amiloid antitijela i njihova upotreba
HUE034512T2 (en) 2007-01-05 2018-02-28 Univ Zuerich A method for providing disease-specific binding molecules and targets
WO2008084402A2 (en) 2007-01-11 2008-07-17 Philipps-Universitaet Marburg Diagnosis and treatment of alzheimer's and other neurodementing diseases
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
US8048420B2 (en) * 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
PT2238166E (pt) 2007-10-05 2014-02-11 Genentech Inc Utilização do anticorpo anti-amilóide beta em doenças oculares
RU2542967C2 (ru) * 2007-10-05 2015-02-27 Дженентек, Инк. Применение антитела против амилоида бета при глазных заболеваниях
EA201190025A1 (ru) 2008-11-25 2012-12-28 Байоджен Айдек Ма Инк. ПРИМЕНЕНИЕ АНТАГОНИСТОВ DR6 И p75 ДЛЯ ПРОМОТИРОВАНИЯ ВЫЖИВАНИЯ КЛЕТОК НЕРВНОЙ СИСТЕМЫ
BRPI0923157B1 (pt) 2008-12-19 2021-12-28 University Of Zürich Anticorpos anti-alfa-sinucleína e seus fragmentos, seus usos e método de preparação, composição compreendendo-os, bem como kit e métodos para o diagnóstico e monitoramento de uma doença sinucleinopática
WO2011060246A2 (en) 2009-11-12 2011-05-19 Genentech, Inc. A method of promoting dendritic spine density
CN102933601B (zh) 2010-04-15 2016-06-08 Abbvie公司 β淀粉样蛋白结合蛋白
MY164579A (en) 2010-07-30 2018-01-15 Ac Immune Sa Safe and functional humanized antibodies
PL3042917T3 (pl) * 2010-08-12 2018-07-31 Eli Lilly And Company Przeciwciała przeciwko peptydowi beta amyloidu N3pGlu i ich zastosowanie
MX358739B (es) 2010-08-14 2018-09-03 Abbvie Inc Star Proteinas de union a amiloide beta.
PL2723379T3 (pl) 2011-06-23 2019-05-31 Biogen Int Neuroscience Gmbh Cząsteczki wiążące przeciwko alfa-synukleinie
US20150209406A1 (en) 2012-09-07 2015-07-30 Massachusetts Eye And Ear Infirmary Methods and compositions for regenerating hair cells and/or supporting cells
WO2014039781A1 (en) 2012-09-07 2014-03-13 Massachusetts Eye & Ear Infirmary Treating hearing loss
JP6751344B2 (ja) 2013-09-13 2020-09-02 ジェネンテック， インコーポレイテッド 精製された組み換えポリペプチドを含む方法及び組成物
MA41115A (fr) 2014-12-02 2017-10-10 Biogen Int Neuroscience Gmbh Procédé de traitement de la maladie d'alzheimer
KR102362222B1 (ko) 2016-05-16 2022-02-11 더 제너럴 하스피탈 코포레이션 폐 상피 공학에서 인간 기도 줄기 세포
WO2018031334A1 (en) * 2016-08-11 2018-02-15 Eli Lilly And Company Aminothiazines and their use as bace1 inhibitors
AU2018321335B2 (en) 2017-08-22 2025-08-14 Biogen Ma Inc. Pharmaceutical compositions containing anti-beta amyloid antibodies
TWI843040B (zh) 2021-01-11 2024-05-21 美商美國禮來大藥廠 抗N3pGlu類澱粉β抗體及其用途
WO2022251048A1 (en) 2021-05-24 2022-12-01 Eli Lilly And Company Anti-amyloid beta antibodies and uses thereof
JP2025506411A (ja) 2022-02-03 2025-03-11 イーライ リリー アンド カンパニー アルツハイマー病の診断及び治療のための局所タウイメージング

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT951466E (pt) 1996-12-23 2009-04-09 Lilly Co Eli Compostos cicloalquilo, lactama, lactona e relacionados, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da libertação do péptido β-amilóide e/ou da sua síntese pela utilização de tais compostos
US6518011B1 (en) * 1999-01-13 2003-02-11 Bristol-Myers Squibb Company Method for screening compounds to identify beta-amyloid production modulators
MXPA02008145A (es) * 2000-02-24 2004-04-05 Univ Washington Anticuerpos humanizados que secuestran al peptido beta amiloide.
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
TWI255272B (en) * 2000-12-06 2006-05-21 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
ES2437875T3 (es) * 2001-04-30 2014-01-14 Eli Lilly And Company Anticuerpos humanizados que reconocen el péptido beta-amiloide

Also Published As

Publication number Publication date
AU2005217596B2 (en) 2012-01-19
US20070190046A1 (en) 2007-08-16
CN1922209B (zh) 2012-09-05
KR20090005410A (ko) 2009-01-13
JP2008500279A (ja) 2008-01-10
SI1720909T1 (sl) 2012-01-31
IL177611A (en) 2013-05-30
DK1720909T3 (da) 2012-01-30
CY1112162T1 (el) 2015-12-09
PL1720909T3 (pl) 2012-04-30
CA2556436C (en) 2014-04-01
EA009872B1 (ru) 2008-04-28
NO20064239L (no) 2006-11-20
EA200601545A1 (ru) 2007-02-27
PT1720909E (pt) 2011-12-23
BRPI0507856A (pt) 2007-07-10
JP4851348B2 (ja) 2012-01-11
KR100889430B1 (ko) 2009-03-23
ES2375627T3 (es) 2012-03-02
UA93181C2 (ru) 2011-01-25
IL177611A0 (en) 2006-12-10
AU2005217596A1 (en) 2005-09-09
KR20060126785A (ko) 2006-12-08
CN1922209A (zh) 2007-02-28
EP1720909A2 (en) 2006-11-15
EP1720909B1 (en) 2011-11-23
CA2556436A1 (en) 2005-09-09
WO2005082939A3 (en) 2005-10-27
WO2005082939A2 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
ATE534667T1 (de) Anti-abeta antikörper
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
CY1121208T1 (el) Σκευασματα αντισωματος ναταλιζουμαμπης
CO5720212A1 (es) Composicion de anticuerpo her2
CU24058B1 (es) Antagonistas de pcsk9
DK3530673T3 (da) Humaniserede anti-beta7-antagonister og anvendelser deraf
EA200800812A1 (ru) Композиции антитела против cd3
EA200901500A1 (ru) Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека
DK1694706T3 (da) Modificeret anti-CD52-antistof
MY174493A (en) Binding agents
EA201291226A1 (ru) Композиции с высокой концентрацией антител
CL2011000010A1 (es) Anticuerpo monoclonal anti-peptido beta-amiloide; polinucleotido que lo codifica; hibridoma; metodo de produccion; composicion que lo comprende; uso para tratar enfermedades relacionadas con proteinas amiloides; metodo de diagnostico de las mismas; y kit que lo comprende.
EA201170323A1 (ru) Антитела против il-12/il-23
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
EA201390467A1 (ru) Композиции антител и способы применения
EA200700702A1 (ru) Аналоги локсапина и способы их применения
ATE550354T1 (de) Humane ringspezifische bnp-antikörper
CO6382184A2 (es) Proteinas fijadoras de receptores de interleukinas-21
DK1987057T3 (da) Peptidaptamer til neutralisering af bindingen af platelet-antigen-specifikke antistoffer og diagnostiske og terapeutiske applikationer indeholdende den.
EA200800601A1 (ru) Связывающие fas антитела
EA200601743A1 (ru) Выделенный полипептид реналазы и его применение
ATE527354T1 (de) Diabetogene epitope
TW200742745A (en) Monoclonal antibody specific to enrofloxacin, hybridoma producing same and kit comprising same
UA106870C2 (uk) Антитіла, специфічні для протофібрилярної форми бета-амілоїдного білка